Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Epstein-Barr Virus

Epstein-Barr virus protein sufficient for transactivation of superantigen

According to a study from the United States, "Superantigens are microbial proteins that strongly stimulate T cells. We described previously that the Epstein-Barr virus (EBV) transactivates a superantigen encoded by the human endogenous retrovirus, HERV-K18. We now report that the transactivation is dependent upon the EBV latent cycle proteins."

"Moreover, LMP-2A is sufficient for induction of HERV-K18 superantigen activity," stated Natalie Sutkowski and colleagues at Tufts University.

...

• View Other Issues of Vaccine Weekly
  
• View Other NewsRx Publications